These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11214235)

  • 21. Characterization of co-purified acellular pertussis vaccines.
    Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
    Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
    Seubert A; D'Oro U; Scarselli M; Pizza M
    Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of solution environment on the purification of pertussis toxin].
    Wu T; Bi J; Huang Y; Zhang Y; Sun L; Sun C; Su Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1279-84. PubMed ID: 18837409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of pertussis toxin subunit proteins by reverse-phase high-performance liquid chromatography and reconstitution of the holotoxin molecule.
    Yamakawa Y; Sato H; Sato Y
    Anal Biochem; 1990 Feb; 185(1):176-81. PubMed ID: 2344043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined use of analytical tools for exploring tetanus toxin and tetanus toxoid structures.
    Bayart C; Peronin S; Jean E; Paladino J; Talaga P; Borgne ML
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1054():80-92. PubMed ID: 28448854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments toward a recombinant pertussis vaccine.
    Burnette WN; Whiteley DW; Mar VL; Burns DL; Kaslow HR; Cieplak W; Keith JM; Bartley TD
    Adv Exp Med Biol; 1989; 251():1-7. PubMed ID: 2692423
    [No Abstract]   [Full Text] [Related]  

  • 28. Physicochemical analysis of purified diphtheria toxoids: is toxoided then purified the same as purified then toxoided?
    Frech C; Hilbert AK; Hartmann G; Mayer K; Sauer T; Bolgiano B
    Dev Biol (Basel); 2000; 103():205-15. PubMed ID: 11214238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical characterization of amandin, the major storage protein in almond (Prunus dulcis L.).
    Sathe SK; Wolf WJ; Roux KH; Teuber SS; Venkatachalam M; Sze-Tao KW
    J Agric Food Chem; 2002 Jul; 50(15):4333-41. PubMed ID: 12105967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid composition and physicochemical properties of mouse beta2-microglobulin.
    Natori T; Tanigaki N; Appella E; Pressman D
    Biochem Biophys Res Commun; 1975 Jul; 65(2):611-7. PubMed ID: 1167266
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of chemical modification of L-asparaginase on its persistence in circulating blood of animals.
    Benbough JE; Wiblin CN; Rafter TN; Lee J
    Biochem Pharmacol; 1979 Mar; 28(6):833-9. PubMed ID: 110336
    [No Abstract]   [Full Text] [Related]  

  • 32. Heterogeneity of human epidermal growth factor/urogastrone from human urine.
    Nishimuro S; Nishimura T; Uchida N; Shirono H; Hiratani H
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):4037-40. PubMed ID: 3937607
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of glutaraldehyde for preparation of immunogenic compounds.
    Ben-Efraim S
    Vaccine; 1991 Dec; 9(12):913. PubMed ID: 1811377
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on proteinases from Ficus carica var. Horaishi. II. Physicochemical properties of ficin A,B,C and D].
    Sugiura M; Sasaki M
    Yakugaku Zasshi; 1973 Jan; 93(1):63-7. PubMed ID: 4736447
    [No Abstract]   [Full Text] [Related]  

  • 35. Pertussis vaccine: formalin as preferred detoxifying agent.
    Cameron J
    Lancet; 1983 Apr; 1(8329):880-1. PubMed ID: 6132214
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of quality control in biotechnology: an analytical perspective.
    Garnick RL; Solli NJ; Papa PA
    Anal Chem; 1988 Dec; 60(23):2546-57. PubMed ID: 3239808
    [No Abstract]   [Full Text] [Related]  

  • 37. [The property of filamentous hemagglutinin of Bordetella pertussis].
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):331-8. PubMed ID: 1845342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical characterisation of the pertussis vaccine.
    Ceccarini C; Contorni M; Costantino P; D'Ascenzi S; Gallo E; Maffei M; Mannucci D; Marsili I; Magagnoli C; Peppoloni S; Rappuoli R; Ravenscroft N; Ricci S
    Dev Biol (Basel); 2000; 103():175-88. PubMed ID: 11214235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preparation of A purified immunogenic pertactin from B. pertussis.
    El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF
    Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
    Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
    Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.